Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xarelto for Prevention of Recurrent Thrombosis in Chronic Portal Vein Thrombosis (RIPORT)
NCT02555111Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in portal vein thrombosis (PVT), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02555111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555111.